"Banner MD Anderson patients experience customized, comprehensive and compassionate cancer care. Patients have a team of experts who understand the nuances of each type of cancer to develop a treatment plan based on his or her unique needs. Our cancer experts include medical oncologists, surgeons, radiation oncologists, physician specialists, nurses and clinical support staff. Clinical nurse navigators work closely with patients, guiding them through their first visit and serving as a single point of contact throughout their care. Learn more about the unprecedented cancer care that is provided at Banner MD Anderson."

During the past decade, Banner MD Anderson Cancer Center conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 47 clinical trials were completed, i.e. on average, 30.1% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 41 clinical trials were completed. i.e. 53.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Banner MD Anderson Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Kite, A Gilead Company" with 9 trials sponsored, "M.D. Anderson Cancer Center" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Banner MD Anderson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Banner MD Anderson Cancer Center" are "Breast Cancer" (8 trials), "Metastatic Breast Cancer" (7 trials), "Pancreatic Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Banner MD Anderson Cancer Center" in a lesser frequency.

Most popular intervention types in "Banner MD Anderson Cancer Center" are "Drug" (141 trials), "Biological" (46 trials), "Other" (25 trials), "Radiation" (19 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (15 trials), "Quality-of-Life Assessment" (14 trials), "Fludarabine" (13 trials), "Cisplatin" (12 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Banner MD Anderson Cancer Center" are 165 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Banner MD Anderson Cancer Center". undefined are not yet recruiting, 51 are recruiting, 53 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Banner MD Anderson Cancer Center, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Banner MD Anderson Cancer Center, 50 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".